Effect of starting metformin on severe and long COVID-19 among people living with type 2 diabetes in England: a new user cohort study in OpenSAFELY-TPP
Introduction: Observational studies report lower COVID-19 mortality among metformin users, but most used prevalent-user designs comparing long-term survivo